Medical Health & Life Science Research News

Global therapeutic landscape of 5-hydroxytryptamine receptor detailed in new research report

Medical Market Research

5-Hydroxytryptamine Receptor 6 Pipeline Review, H2 2017, outlays comprehensive information on the 5-Hydroxytryptamine Receptor 6 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) The 5-HT6 receptor is a subtype of 5-HT receptor that binds the endogenous neurotransmitter serotonin. Blockade of 5-HT6 receptors showed to increase glutamatergic and cholinergic neurotransmission in brain, whereas activation enhances GABAergic signaling in a widespread manner.

Antagonism of 5-HT6 receptors facilitates dopamine and norepinephrine release in the frontal cortex while stimulation has the opposite effect. 5-HT6 receptor plays an important role in Alzheimer's disease and other forms of dementia and obesity.

Report Source: www.themarketreports.com/report/5-…e-review-h2-2017

Scope

  • The report provides a snapshot of the global therapeutic landscape for 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6)
  • The report reviews 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in 5-Hydroxytryptamine Receptor 6 (5 HT6 or Serotonin Receptor 6 or HTR6) targeted therapeutics and enlists all their major and minor projects

Report available at: www.themarketreports.com/report/buy-now/941408

Companies Mentioned

  • Acorda Therapeutics Inc
  • Adamed Sp z oo
  • Avineuro Pharmaceuticals Inc
  • Axovant Sciences Ltd
  • Celon Pharma SA
  • Galenea Corp
  • Lundbeck A/S
  • Reviva Pharmaceuticals Inc
  • Suven Life Sciences Ltd
  • Teva Pharmaceutical Industries Ltd

Got a question; ask us at: www.themarketreports.com/report/ask-your-query/941408

News From

The Market Reports - Industry & Market Reports at its BESTThe Market Reports
Category: Market Research Publishers and RetailersCompany about: The Market Reports aims to provide the best industry and market reports to a seeker. We are looking forward to a place where we are the one stop destination for all the report seekers irrespective of any country, category, domain, etc. We are always open on call and email (24*7) to your queries and very clean with the business methodology. Since we are dealing with so many Publishers, we can actually give you what suits best in accordance to your requirements.
This email address is being protected from spambots. You need JavaScript enabled to view it.